Nahdi Medical Company
4164
Classement en actions
#4862
Nahdi Medical Company stands as a prominent pharmaceutical retail chain with... Nahdi Medical Company stands as a prominent pharmaceutical retail chain with operations spanning both the Kingdom of Saudi Arabia and the United Arab Emirates. Its extensive product portfolio encompasses a diverse range of pharmaceutical goods, health and wellness items, maternal and infant care essentials, beauty products, and various fast-moving consumer goods. Beyond retail, Nahdi provides a comprehensive suite of omni-health services, including polyclinics, rapid-care clinics, telemedicine platforms, laboratory facilities, and home healthcare programs. The company is also actively involved in the wholesale and retail distribution of cosmetics, medicines, specialized dietary products, healthy food options, and medical equipment. With approximately 1,151 pharmacies under its management, Nahdi Medical Company was established in 1986 and maintains its headquarters in Jeddah, Saudi Arabia. It operates as a subsidiary under the umbrella of both Alnahdi Holding Company Limited and Saudi Economic and Development Company Limited.
Prix de l'action
$23.42
Capitalisation boursière
$3.05B
Changement (1 jour)
-0.45%
Changement (1 an)
-27.09%
Pays
SA
Échange Nahdi Medical Company (4164)
Catégorie
Healthcare
Bénéfices pour Nahdi Medical Company (4164)
Bénéfices en Jun 2026 TTM : $217.74M
Selon les derniers rapports financiers de Nahdi Medical Company, les bénéfices actuels de l'entreprise sont de $217.74M. En 2023, l'entreprise a réalisé un bénéfice de $251.81M, une augmentation par rapport à celui de 2022 qui était de $249.53M. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Nahdi Medical Company de 2017 à 2026
Bénéfices à la fin de chaque année
| Année | Bénéfices | Changez |
|---|---|---|
| 2026 (TTM) | $217.74M | -1.98% |
| 2024 | $222.14M | -11.78% |
| 2023 | $251.81M | 0.91% |
| 2022 | $249.53M | 9.27% |
| 2021 | $228.35M | -4.23% |
| 2020 | $238.42M | 16.36% |
| 2019 | $204.91M | 20.34% |
| 2018 | $170.27M | -15.09% |
| 2017 | $200.53M | 0.00% |
Bénéfices des entreprises similaires ou concurrentes
| Entreprise | Bénéfices | Différence de bénéfices | Pays |
|---|---|---|---|
| $1.35B | 519.94% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| $26.37M | -87.89% |
US
|
